Zentek Ltd. (CVE:ZEN - Get Free Report)'s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$1.31 and traded as low as C$0.99. Zentek shares last traded at C$1.10, with a volume of 61,541 shares.
Zentek Price Performance
The company has a quick ratio of 7.59, a current ratio of 2.20 and a debt-to-equity ratio of 5.91. The firm has a market capitalization of C$114.46 million, a PE ratio of -9.17 and a beta of 0.77. The firm's fifty day simple moving average is C$1.06 and its 200-day simple moving average is C$1.30.
Zentek (CVE:ZEN - Get Free Report) last released its quarterly earnings data on Monday, August 12th. The mining company reported C($0.03) earnings per share for the quarter. The firm had revenue of C$0.01 million for the quarter. On average, research analysts forecast that Zentek Ltd. will post -0.1 earnings per share for the current fiscal year.
Zentek Company Profile
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
See Also
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.